EpiPen�s overpricing issue is bothering Mylan $MYL. Last week, CEO Heather Bresch, testifying before a congressional committee said that the company�s profit for a two-pack EpiPens was $100, although the list price shows $608. Separately, in a response to questions from the WSJ, Mylan said that the figure included taxes, which it did not convey it to the committee. The drug-maker significantly lowered its profit calculation by applying a corporate tax rate of 37.5%, which is 5x its overall tax rate of last year.